Cargando…

Pharmacologic Inhibition of β-Catenin With Pyrvinium Inhibits Murine and Human Models of Wilms Tumor

Wilms tumor (WT) is the most common renal malignancy in children and the fourth most common pediatric solid malignancy in the US. Although the mechanisms underlying the WT biology are complex, these tumors most often demonstrate activation of the canonical Wnt/β-catenin pathway. We and others have s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Polosukhina, Dina, Love, Harold D., Moses, Harold L., Lee, Ethan, Zent, Roy, Clark, Peter E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cognizant Communication Corporation 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5670010/ https://www.ncbi.nlm.nih.gov/pubmed/28695795 http://dx.doi.org/10.3727/096504017X14992942781895

Ejemplares similares

Functional KRAS mutations and a potential role for PI3K/AKT activation in Wilms tumors
por: Polosukhina, Dina, et al.
Publicado: (2017)

Anthelmintic pyrvinium pamoate blocks Wnt/β-catenin and induces apoptosis in multiple myeloma cells
por: Xu, Fang, et al.
Publicado: (2020)

Pyrvinium Treatment Confers Hepatic Metabolic Benefits via β-catenin Downregulation and AMPK Activation
por: Zhou, Shiwei, et al.
Publicado: (2021)

Targeting of Wnt/β-Catenin by Anthelmintic Drug Pyrvinium Enhances Sensitivity of Ovarian Cancer Cells to Chemotherapy
por: Zhang, Chongyuan, et al.
Publicado: (2017)

β-catenin inhibitors ICG-001 and pyrvinium sensitize bortezomib-resistant multiple myeloma cells to bortezomib
por: Wu, Cuicui
Publicado: (2022)

Pyrvinium pamoate regulates MGMT expression through suppressing the Wnt/β-catenin signaling pathway to enhance the glioblastoma sensitivity to temozolomide
por: Li, Haisong, et al.
Publicado: (2021)

Pyrvinium selectively targets blast phase-chronic myeloid leukemia through inhibition of mitochondrial respiration
por: Xiang, Wei, et al.
Publicado: (2015)

Niclosamide and Pyrvinium Are Both Potential Therapeutics for Osteosarcoma, Inhibiting Wnt–Axin2–Snail Cascade
por: Yi, Young, et al.
Publicado: (2021)

Biological Drivers of Wilms Tumor Prognosis and Treatment
por: Phelps, Hannah M., et al.
Publicado: (2018)

Tumor Suppressive Role of MUC6 in Wilms Tumor via Autophagy-Dependent β-Catenin Degradation
por: Liu, Bai-Hui, et al.
Publicado: (2022)

Genetic and chromosomal alterations in Kenyan Wilms Tumor
por: Lovvorn, Harold N., et al.
Publicado: (2015)

The Antihelmintic Drug Pyrvinium Pamoate Targets Aggressive Breast Cancer
por: Xu, Wei, et al.
Publicado: (2013)

Pyrvinium doubles against WNT-driven cancer
por: Fan, Jiaming, et al.
Publicado: (2022)

Pyrvinium pamoate inhibits cell proliferation through ROS-mediated AKT-dependent signaling pathway in colorectal cancer
por: Zheng, Wenqian, et al.
Publicado: (2021)

SIX2 Effects on Wilms Tumor Biology()
por: Pierce, Janene, et al.
Publicado: (2014)

Pyrvinium Pamoate and Structural Analogs Are Early Macrofilaricide Leads
por: Gunderson, Emma L., et al.
Publicado: (2022)

PRMT5 acts as a tumor suppressor by inhibiting Wnt/β-catenin signaling in murine gastric tumorigenesis
por: Tang, Yuling, et al.
Publicado: (2022)

RETRACTED: Zhou et al. Pyrvinium Treatment Confers Hepatic Metabolic Benefits via β-Catenin Downregulation and AMPK Activation. Pharmaceutics 2021, 13, 330
por: Zhou, Shiwei, et al.
Publicado: (2023)

Inhibition of Wilms' Tumor Proliferation and Invasion by Blocking TGF-β Receptor I in the TGF-β/Smad Signaling Pathway
por: Shi, Qinlin, et al.
Publicado: (2020)

Pyrvinium targets autophagy addiction to promote cancer cell death
por: Deng, Longfei, et al.
Publicado: (2013)

Pyrvinium Pamoate: Past, Present, and Future as an Anti-Cancer Drug
por: Schultz, Christopher W., et al.
Publicado: (2022)

Wilms Tumor in Sub-Saharan Africa: Molecular and Social Determinants of a Global Pediatric Health Disparity
por: Apple, Annie, et al.
Publicado: (2020)

Overexpression of cytoplasmic β-catenin inhibits the metastasis of the murine osteosarcoma cell line LM8
por: Kidani, Teruki, et al.
Publicado: (2014)

Wilms’ Tumor 1-Associated Protein Contributes to Chemo-Resistance to Cisplatin Through the Wnt/β-Catenin Pathway in Endometrial Cancer
por: Xie, Wenli, et al.
Publicado: (2021)

Repurposing the FDA-Approved Pinworm Drug Pyrvinium as a Novel Chemotherapeutic Agent for Intestinal Polyposis
por: Li, Bin, et al.
Publicado: (2014)

Pyrvinium, a Potent Small Molecule Wnt Inhibitor, Promotes Wound Repair and Post-MI Cardiac Remodeling
por: Saraswati, Sarika, et al.
Publicado: (2010)

Mechanistic Investigation of the Androgen Receptor DNA-Binding Domain Inhibitor Pyrvinium
por: Pal, Sumanta K., et al.
Publicado: (2019)

Pyrvinium pamoate can overcome artemisinin’s resistance in anaplastic thyroid cancer
por: Li, Yitian
Publicado: (2021)

Pyrvinium Targets the Unfolded Protein Response to Hypoglycemia and Its Anti-Tumor Activity Is Enhanced by Combination Therapy
por: Yu, De-Hua, et al.
Publicado: (2008)

STAT3 paradoxically stimulates β-catenin expression but inhibits β-catenin function
por: Ibrahem, Salih, et al.
Publicado: (2014)

Exploiting embryonic niche conditions to grow Wilms tumor blastema in culture
por: Wojcik, Heather M., et al.
Publicado: (2023)

CITED1 confers stemness to Wilms tumor and enhances tumorigenic responses when enriched in the nucleus
por: Murphy, Andrew J., et al.
Publicado: (2013)

Tumor de Wilms.:
por: González Ortiz, María de los Angeles
Publicado: (1994)

Tumor de Wilms/
por: González Ortíz, María de los Angeles
Publicado: (1994)

Wilms' tumor: An update
por: Tongaonkar, Hemant B., et al.
Publicado: (2007)

Phylogeny of Wilms tumor?
por: Charles, Adrian, et al.
Publicado: (2016)

Wilms' tumor of the ovary
por: Alexander, Vinita M., et al.
Publicado: (2016)

Inhibition of β‐catenin/CBP signalling improves airway epithelial barrier function and suppresses CCL20 release
por: Kuchibhotla, Virinchi N. S., et al.
Publicado: (2020)

β-Catenin inhibition shapes tumor immunity and synergizes with immunotherapy in colorectal cancer
por: Wang, Caihong, et al.
Publicado: (2020)

Inhibition of Wnt/β-Catenin Signaling in Neuroendocrine Tumors In Vitro: Antitumoral Effects
por: Jin, Xi-Feng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bqkgt5bka08cm18546q4d1hr36